More articles from Cystic fibrosis

Electronic nose (E-nose) analysis of exhaled volatile organic compounds (VOCs) distinguishes pediatric patients (pts) with Cystic fibrosis (CF) from healthy controls (HC) and depicts disease status
Francesca Lucca, Sonia Volpi, Laura Tenero, Michele Piazza, Marco Sandri, Marco Cipolli, Giorgio Piacentini

European Respiratory Journal Sep 2020, 56 (suppl 64) 353; DOI: 10.1183/13993003.congress-2020.353
Assessment of Lumacaftor/Ivacaftor therapy on physical activity and exercise tolerance in adults with cystic fibrosis
Alessandro Porcella, Andrea Gramegna, Marcello Di Paolo, Marco Vicenzi, Irene Rota, Carlotta Biglia, Barbara Messore, Emanuela Leggieri, Francesco Blasi, Paolo Palange, Daniela Savi

European Respiratory Journal Sep 2020, 56 (suppl 64) 364; DOI: 10.1183/13993003.congress-2020.364
A retrospective observational study: Bidirectional pharmacokinetic interactions between ivacaftor-lumacaftor in cystic fibrosis
Elena Schneider, Patrick Hanafin, Gauri Rao

European Respiratory Journal Sep 2020, 56 (suppl 64) 362; DOI: 10.1183/13993003.congress-2020.362
“Lung clearence index”; Can it be a guide for long-term follow up of children with cystic fibrosis who have normal spirometric values?
Beste Ozsezen, Ebru Yalcin, Nagehan Emiralioglu, Dilber Ademhan Tural, Canan Caka, Birce Sunman, Deniz Dogru, Ugur Ozcelik, Nural Kiper

European Respiratory Journal Sep 2020, 56 (suppl 64) 357; DOI: 10.1183/13993003.congress-2020.357
Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population
Yunus Çolak, Børge G. Nordestgaard, Shoaib Afzal

European Respiratory Journal Sep 2020, 56 (3) 2000558; DOI: 10.1183/13993003.00558-2020
Structural determinants of long-term functional outcomes in young children with cystic fibrosis
Lidija Turkovic, Daan Caudri, Tim Rosenow, Oded Breuer, Conor Murray, Harm A.W.M. Tiddens, Fiona Ramanauskas, Sarath C. Ranganathan, Graham L. Hall, Stephen M. Stick

European Respiratory Journal May 2020, 55 (5) 1900748; DOI: 10.1183/13993003.00748-2019
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Naomi E. Wijker, Suzanna Vidmar, Keith Grimwood, Peter D. Sly, Catherine A. Byrnes, John B. Carlin, Peter J. Cooper, Colin F. Robertson, R. John Massie, Mariette P.C. Kemner van de Corput, Joyce Cheney, Harm A.W.M. Tiddens, Claire E. Wainwright

European Respiratory Journal Apr 2020, 55 (4) 1901694; DOI: 10.1183/13993003.01694-2019
An evaluation of a novel disposable Oscillating Positive Expiratory Pressure (OPEP) device in children with Cystic Fibrosis
Kevin O’Sullivan, Valerie Power, Colum Dunne, Leonard O’Sullivan, Barry Linnane, Deirdre Mcgrath

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4530; DOI: 10.1183/13993003.congress-2019.PA4530
The pharmacokinetic of the main oral antibiotics in children with cystic fibrosis
Yulia Kondakova, Elena Kondratyeva, Sergey Zyryanov, Irina Bondareva, Victoria Sherman, Yuliya Melyanovskaya

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4519; DOI: 10.1183/13993003.congress-2019.PA4519
Patient centred research: a model for involving cystic fibrosis (CF) patients in research planning
Brooke Bianco, Huziafa Patel, Emma Shaw Nunez, Amanda Brennan, Susan Kirk, Alex Horsley

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4526; DOI: 10.1183/13993003.congress-2019.PA4526

Main menu

User menu

Search

More articles from Cystic fibrosis

Pages

Contact us